MetLife Investment Management’s Houghton Mifflin Harcourt Company HMHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-67,907
| Closed | -$1.43M | – | 2955 |
|
|
2022
Q1 | $1.43M | Buy |
67,907
+23,549
| +53% | +$444K | 0.01% | 1140 |
|
|
2021
Q4 | $714K | Hold |
44,358
| – | – | 0.01% | 1299 |
|
|
2021
Q3 | $596K | Buy |
44,358
+3,669
| +9% | +$46.2K | 0.01% | 1424 |
|
|
2021
Q2 | $449K | Hold |
40,689
| – | – | ﹤0.01% | 1631 |
|
|
2021
Q1 | $310K | Buy |
40,689
+22,427
| +123% | +$128K | ﹤0.01% | 1796 |
|
|
2020
Q4 | $60.8K | Buy |
18,262
+5,714
| +46% | +$17K | ﹤0.01% | 2250 |
|
|
2020
Q3 | $21.7K | Sell |
12,548
-42,789
| -77% | -$95.6K | ﹤0.01% | 2282 |
|
|
2020
Q2 | $100K | Buy |
55,337
+5,512
| +11% | +$8.85K | ﹤0.01% | 2255 |
|
|
2020
Q1 | $93.7K | Buy |
49,825
+20,422
| +69% | +$104K | ﹤0.01% | 2108 |
|
|
2019
Q4 | $184K | Sell |
29,403
-16,731
| -36% | -$97.7K | ﹤0.01% | 2020 |
|
|
2019
Q3 | $246K | Hold |
46,134
| – | – | ﹤0.01% | 1825 |
|
|
2019
Q2 | $266K | Hold |
46,134
| – | – | ﹤0.01% | 1868 |
|
|
2019
Q1 | $335K | Hold |
46,134
| – | – | ﹤0.01% | 1694 |
|
|
2018
Q4 | $409K | Buy |
46,134
+12,029
| +35% | +$95.1K | 0.01% | 1491 |
|
|
2018
Q3 | $239K | Sell |
34,105
-14,605
| -30% | -$98.5K | ﹤0.01% | 1986 |
|
|
2018
Q2 | $373K | Buy |
48,710
+13,857
| +40% | +$98.4K | ﹤0.01% | 1592 |
|
|
2018
Q1 | $242K | Sell |
34,853
-13,960
| -29% | -$110K | ﹤0.01% | 1787 |
|
|
2017
Q4 | $454K | Buy |
+48,813
| New | +$487K | 0.01% | 1450 |
|
Other funds holding HMHC
MetLife Investment Management's HMHC Position: Q2 2022 in Review
MetLife Investment Management sold out of Houghton Mifflin Harcourt Company (HMHC) in Q2 2022, closing a stake of 67,907 shares — an estimated $1.43M sold.
MetLife Investment Management first reported a position in HMHC in Q4 2017 and held it in 18 quarters. The position peaked at $1.43M in Q1 2022. 1 fund tracked by Wall St. Rank holds HMHC as of Q2 2022.
- MetLife Investment Management reported no remaining Houghton Mifflin Harcourt Company position as of Q2 2022 after selling out during the quarter.
- MetLife Investment Management sold 67,907 Houghton Mifflin Harcourt Company shares in Q2 2022, an estimated $1.43M.
- MetLife Investment Management first reported a position in Houghton Mifflin Harcourt Company in Q4 2017 and held it in 18 quarters.
- MetLife Investment Management's Houghton Mifflin Harcourt Company position peaked at $1.43M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Houghton Mifflin Harcourt Company as of Q2 2022.
Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.